William J. Barson, MD

William J. Barson, MD, is Director of the Infectious Diseases Fellowship program, a member of the Section of Infectious Diseases at Nationwide Children’s Hospital, and Professor of Pediatrics at The Ohio State University College of Medicine. Additionally, he serves as the Chair of Nationwide Children’s Hospital’s Pharmacy and Therapeutics Committee. His clinical interests include the diagnosis and management of infants, children, and adolescents with infectious diseases. His research interests are primarily associated with multi-center surveillance studies of Streptococcus pneumoniae and Neisseria meningitidis infections in children and he is the local Principal Investigator of the U.S. Pediatric Multicenter Pneumococcal Surveillance and the U.S. Pediatric Multicenter Meningococcal Surveillance Study Groups. He has also been involved with a number of antibiotic efficacy and safety studies.

Gender:

• Male

Languages Spoken:

• English

Medical School

• Ohio State University
  Date Completed: 06/30/1975

Internship

• Nationwide Children's Hospital
  Date Completed: 06/30/1976

Residency

• Nationwide Children's Hospital
  Date Completed: 06/30/1978

Fellowship

• Nationwide Children's Hospital
  Date Completed: 06/30/1980

Department:

• Pediatrics

Section:

• Infectious Diseases

Speciality:

• Pediatric Infectious Diseases
  
• Pediatrics
  

Date of Appointment at Nationwide Children’s Hospital:

• 07/01/1980

• William J. Barson and Mario J. Marcon. 2012. Proteus, Providencia, and Morganella Species. In Principles and Practice of Pediatric Infectious Diseases. Fourth ed. Edited by Sarah Long, Larry Pickering, Charles Prober. New York: Elsevier Inc..
• William J. Barson and Mario J. Marcon. 2012. Klebsiella and Raoultella Species. In Principles and Practices of Pediatric Infectious Diseases. Fourth ed. Edited by Sarah Long, Larry Pickering, Charles Prober. New York: Elsevier Inc..
• Green MC, Mason EO, Kaplan SL, et al. 2011. Increase of Streptococcus pneumoniae serotyep 6C at 8 children's hospitals in the United States from 1993-2009.  Journal of Clinical Microbiology. Vol. 49, no. January: e2097.
• Kaplan SL; Barson WJ; Lin PL; Stovall SH; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Mason EO Jr. 2010. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.  Pediatrics. Vol. 125, no. 3. (March): e429.
• Gill K, Zachary B, Williams C, Raffel C, Bouei D, Barson WJ. 2010. Recurrent meningitis in a teenager.  Pediatr Infect Dis J. Vol. 29, no. January: 984-989.
• Bolton M, Barson WJ. 2010. Invasive pneumococcal disease and the need for the new 13-valent pneumococcal vaccine.  Pediatric Ann. Vol. 39, no. January: 497-503.
• Rajasingham CR, Bonsu BK, Chapman JI, Cohen DM, Barson WJ. 2008. Serious neurologic sequelae in cases of meningitis arising from infection by conjugate vaccine-related and nonvaccine-related serogroups of Streptococcus pneumoniae.  Pediatr Infect Dis J. Vol. 27, no. 9. (September): 771-775.
• Barson WJ, Marcon MJ. 2008. Klebsiella and Raoultella Species. In Principles and Practices of Pediatric Infectious Diseases, Third Edition. Edited by Long SS, Pickering LK and Prober CG. St. Louis, MO: Churchill Livingstone/Elsevier.
• Baron WJ, Marcon MJ. 2008. Proteus, Providencia, and Morganella Species. In Principles and Practices of Pediatric Infectious Diseases, Third Edition. Edited by Long SS, Pickering LK and Prober CH. St. Louis, MO: Churchill Livingstone/Elsevier.
• Mason EO Jr; Wald ER; Tan TQ; Schutze GE; Bradley JS; Barson WJ; Givner LB; Hoffman J; Kaplan SL. 2007. Recurrent systemic pneumococcal disease in children.  The Pediatric Infectious Disease Journal. Vol. 26, no. 6. (June): e480.
• Kaplan SL; Schutze GE; Leake JA; Barson WJ; Halasa NB; Byington CL; Woods CR; Tan TQ; Hoffman JA; Wald ER; Edwards KM; Mason EO Jr. 2006. Multicenter surveillance of invasive meningococcal infections in children.  Pediatrics. Vol. 118, no. 4. (October): ee979.
• Freeman AF, Davis J, Anderson VL, Barson W, et al. 2006. Pneumocystis jiroveci infection in pateints with hyper-immunoglobulin E syndrome.  Pediatrics. Vol. 118, no. January: e1271-e1275.
• Koranyi KI; Barson WJ; Studley JK. 2005. Meningitis in a young infant.  The Pediatric Infectious Disease Journal. Vol. 24, no. 4. (April): e387.
• Givner LB; Mason EO Jr; Tan TQ; Barson WJ; Schutze GE; Wald ER; Bradley JS; Hoffman J; Yogev R; Kaplan SL. 2004. Pneumococcal endocarditis in children.  Clinical Infectious Diseases: An Official Publication Of The Infectious Diseases Society Of America. Vol. 38, no. 9. (May): e1273.
• Kaplan SL; Mason EO Jr; Wald ER; Schutze GE; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Yogev R; Barson WJ. 2004. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.  Pediatrics. Vol. 113, no. 3 Pt 1. (March): e443.
• Gonzalez BE, Hulten KG, Kaplan SL, et al. 2004. Clonality of Streptococcus pneumoniae serotype 1 isolates from pediatric patients in the United States.  Journal of Clinical Microbiology. Vol. 42, no. January: 2810-2812.
• Hoffman JA; Mason EO; Schutze GE; Tan TQ; Barson WJ; Givner LB; Wald ER; Bradley JS; Yogev R; Kaplan SL. 2003. Streptococcus pneumoniae infections in the neonate.  Pediatrics. Vol. 112, no. 5. (November): e1095.
• Mason EO Jr; Wald ER; Bradley JS; Barson WJ; Kaplan SL. 2003. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.  The Pediatric Infectious Disease Journal. Vol. 22, no. 7. (July): e623.
• Mason EO Jr; Lamberth LB; Wald ER; Bradley JS; Barson WJ; Kaplan SL. 2003. In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides.  Antimicrobial Agents And Chemotherapy. Vol. 47, no. 1. (January): e166.
• Tan TQ; Mason EO Jr; Wald ER; Barson WJ; Schutze GE; Bradley JS; Givner LB; Yogev R; Kim KS; Kaplan SL. 2002. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae.  Pediatrics. Vol. 110, no. 1 Pt 1. (July): e1.
• Schutze GE; Mason EO Jr; Barson WJ; Kim KS; Wald ER; Givner LB; Tan TQ; Bradley JS; Yogev R; Kaplan SL. 2002. Invasive pneumococcal infections in children with asplenia.  The Pediatric Infectious Disease Journal. Vol. 21, no. 4. (April): e278.
• Kaplan SL; Mason EO Jr; Wald E; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R; Barson WJ. 2002. Six year multicenter surveillance of invasive pneumococcal infections in children.  The Pediatric Infectious Disease Journal. Vol. 21, no. 2. (February): e141.
• Schutze GE; Mason EO Jr; Wald ER; Barson WJ; Bradley JS; Tan TQ; Kim KS; Givner LB; Yogev R; Kaplan SL. 2001. Pneumococcal infections in children after transplantation.  Clinical Infectious Diseases: An Official Publication Of The Infectious Diseases Society Of America. Vol. 33, no. 1. (July): e16.
• Kaplan SL; Mason EO Jr; Barson WJ; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R; Wald ER. 2001. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.  The Pediatric Infectious Disease Journal. Vol. 20, no. 4. (April): e392.
• Wald ER; Mason EO Jr; Bradley JS; Barson WJ; Kaplan SL. 2001. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997.  The Pediatric Infectious Disease Journal. Vol. 20, no. 1. (January): e34.
• Givner LB; Mason EO Jr; Barson WJ; Tan TQ; Wald ER; Schutze GE; Kim KS; Bradley JS; Yogev R; Kaplan SL. 2000. Pneumococcal facial cellulitis in children.  Pediatrics. Vol. 106, no. 5. (November): eE61.
• Kaplan SL; Mason EO Jr; Wald ER; Kim KS; Givner LB; Bradley JS; Barson WJ; Tan TQ; Schutze GE; Yogev R. 2000. Pneumococcal mastoiditis in children.  Pediatrics. Vol. 106, no. 4. (October): e695.
• Azimi PH; Barson WJ; Janner D; Swanson R. 1999. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.  The Pediatric Infectious Disease Journal. Vol. 18, no. 7. (July): e609.
• Bradley JS; Kaplan SL; Tan TQ; Barson WJ; Arditi M; Schutze GE; Wald ER; Givner LB; Mason EO. 1998. Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG).  Pediatrics. Vol. 102, no. 6. (December): e1376.
• Tan TQ; Mason EO Jr; Barson WJ; Wald ER; Schutze GE; Bradley JS; Arditi M; Givner LB; Yogev R; Kim KS; Kaplan SL. 1998. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.  Pediatrics. Vol. 102, no. 6. (December): e1369.
• Arditi M; Mason EO Jr; Bradley JS; Tan TQ; Barson WJ; Schutze GE; Wald ER; Givner LB; Kim KS; Yogev R; Kaplan SL. 1998. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.  Pediatrics. Vol. 102, no. 5. (November): e1087.
• Barson WJ. 1998. Probable actinic Rocky Mountain spotted fever.  The Pediatric Infectious Disease Journal. Vol. 17, no. 9. (September): e850.
• Kaplan SL; Mason EO Jr; Barson WJ; Wald ER; Arditi M; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R. 1998. Three-year multicenter surveillance of systemic pneumococcal infections in children.  Pediatrics. Vol. 102, no. 3 Pt 1. (September): e538.
• Bates RD; Nahata MC; Jones JW; McCoy K; Young G; Cox S; Barson WJ. 1997. Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis.  Chest. Vol. 112, no. 5. (November): e1208.
• Sferra TJ; Barson WJ. 1997. Escherichia coli arthritis as the presenting manifestation of posterior urethral valves.  The Pediatric Infectious Disease Journal. Vol. 16, no. 2. (February): e260.
• Shaffer JP, Allen E, Groner JI, Barson W, Lequette M, Hogan MJ. 1997. Massive hemoptysis as the presenting manifestation in a child with histoplasmosis.  Pediatric Pulmonology. Vol. 24, no. January: 57-60.
• Barson WJ; Marcon MJ. 1996. Successful therapy of Candida albicans arthritis with a sequential intravenous amphotericin B and oral fluconazole regimen.  The Pediatric Infectious Disease Journal. Vol. 15, no. 12. (December): e1119.
• Pacini DL; Trevorrow T; Rao MK; Birck HG; Barson WJ. 1996. Malignant external otitis as the presentation of childhood acute lymphocytic leukemia.  The Pediatric Infectious Disease Journal. Vol. 15, no. 12. (December): e1132.
• Nahata MC; Barson WJ; Puri SK. 1995. Pharmacokinetics of cefpirome in pediatric patients.  Antimicrobial Agents And Chemotherapy. Vol. 39, no. 10. (October): e2348.
• Wald ER, Kaplan SL, Mason EO, Sado D, Russ L, Arditi M, Wiederman BL, Barson W, Kim KS, Yogev R, Hofkosh D. 1995. Dexamethasone therapy for children with bacterial meningitis.  Pediatrics. Vol. 95, no. January: 21-28.
• Chattoraj MR, Barson W, McClead RE. 1994. Neonatal osteomyelitis. Radiological Case of the Month.  Archives of Pediatric and Adolescent Medicine. Vol. 148, no. January: 1305-1306.
• Nahata MC; Kohlbrenner VM; Barson WJ. 1993. Pharmacokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children.  Chemotherapy. Vol. 39, no. 1. (January): e1.
• Spearman PW; Barson WJ. 1992. Toxic shock syndrome occurring in children with abrasive injuries beneath casts.  Journal Of Pediatric Orthopedics. Vol. 12, no. 2. (March): e169.
• Barson WJ. 1991. Group A streptococcal toxic shock-like syndrome.  The Pediatric Infectious Disease Journal. Vol. 10, no. 12. (December): e958.
• Barson WJ; Fortney JL. 1990. Staphylococcus aureus osteomyelitis associated with varicella infection.  The Pediatric Infectious Disease Journal. Vol. 9, no. 2. (February): e146.
• Nahata MC; Fan-Havard P; Barson WJ; Bartkowski HM; Kosnik EJ. 1990. Pharmacokinetics, cerebrospinal fluid concentration, and safety of intravenous rifampin in pediatric patients undergoing shunt placements.  European Journal Of Clinical Pharmacology. Vol. 38, no. 5. (January): e515.
• Fan-Havard P; Nahata MC; Bartkowski MH; Barson WJ; Kosnik EJ. 1990. Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement.  Chemotherapy. Vol. 36, no. 2. (January): e103.
• Nahata MC, Durrell DE, Barson WJ. 1990. Pharmocokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children with bacterial meningitis.  Pharmacotherapy. Vol. 10, no. January: 238-242.
• Nahata MC; Fan-Havard P; Kosnik EJ; Bartkowski MH; Barson WJ. 1990. Pharmacokinetics and cerebrospinal fluid concentration of nafcillin in pediatric patients undergoing cerebrospinal fluid shunt placement.  Chemotherapy. Vol. 36, no. 2. (January): e98.
• Barson WJ. 1989. Treatment of Bacillus infections.  Pediatrics. Vol. 84, no. 2. (August): e403.
• Fan-Havard P; Nahata MC; Barson WJ; Bartkowski H; Kosnik E. 1988. Histamine-like reaction after a single intravenous dose of rifampin.  Clinical Pharmacy. Vol. 7, no. 8. (August): e616.
• Lin YC; King DR; Birken GA; Barson WJ. 1988. Acute scrotum due to Haemophilus influenzae type b.  Journal Of Pediatric Surgery. Vol. 23, no. 2. (February): e183.
• Barson WJ; Brady MT. 1987. Management of infections in children with cancer.  Hematology/Oncology Clinics Of North America. Vol. 1, no. 4. (December): e801.
• Barson WJ; Cromer BA; Marcon MJ. 1987. Puncture wound osteochondritis of the foot caused by CDC group Vd.  Journal Of Clinical Microbiology. Vol. 25, no. 10. (October): e2014.
• Brady MT; Barson WJ; Cannon HJ Jr; Grossman LK. 1987. Onset of Hemophilus influenzae type-b meningitis during cefaclor therapy for preseptal cellulitis.  Clinical Pediatrics. Vol. 26, no. 3. (March): e132.
• Barson WJ; Reiner CB. 1986. Coxsackievirus B2 infection in a neonate with incontinentia pigmenti.  Pediatrics. Vol. 77, no. 6. (June): e897.
• Barson WJ. 1986. Anterior uveitis associated with septic staphylococcal scarlet fever.  Pediatric Infectious Disease. Vol. 5, no. 3. (May): e385.
• Barson WJ. 1986. Group C streptococcal osteomyelitis.  Journal Of Pediatric Orthopedics. Vol. 6, no. 3. (May): e346.
• Barson WJ; Ruymann FB. 1986. Palmar aspergillosis in immunocompromised children.  Pediatric Infectious Disease. Vol. 5, no. 2. (March): e264.
• Nahata MC; Durrell DE; Barson WJ. 1986. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.  Chemotherapy. Vol. 32, no. 2. (January): e89.
• Barson WJ. 1986. Branhamella catarrhalis scalp absces complicating intrapartum monitoring.  Clinical Pediatrics. Vol. 25, no. January: 394-394.
• Nahata MC; Barson WJ. 1985. Ceftriaxone: a third-generation cephalosporin.  Drug Intelligence & Clinical Pharmacy. Vol. 19, no. 12. (December): e900.
• Barson WJ; Miller MA; Marcon MJ; Hribar MM; Brady MT; Pacini DL; Powell DA. 1985. Cefuroxime therapy for bacteremic soft-tissue infections in children.  American Journal Of Diseases Of Children (1960). Vol. 139, no. 11. (November): e1141.
• Barson WJ; Miller MA; Brady MT; Powell DA. 1985. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children.  Pediatric Infectious Disease. Vol. 4, no. 4. (July): e362.
• Barson WJ. 1985. Granuloma and pseudogranuloma of the skin due to Microsporum canis. Successful management with local injections of miconazole.  Archives Of Dermatology. Vol. 121, no. 7. (July): e895.
• Furman WL; Menke JA; Barson WJ; Miller RR. 1984. Continuous naloxone infusion in two neonates with septic shock.  The Journal Of Pediatrics. Vol. 105, no. 4. (October): e649.
• Westman JA; Barson WJ; Powell DA. 1984. Dactylitis and tuberculid eruptions in a child with primary tuberculosis.  Pediatric Infectious Disease. Vol. 3, no. 3. (May): e251.
• Barson WJ; Miller MA. 1984. Relapse of Haemophilus influenzae type b meningitis following therapy with ceftriaxone.  Pediatric Infectious Disease. Vol. 3, no. 3. (May): e241.
• Nahata MC; Powell DA; Glazer JP; Barson WJ. 1982. Teaching pediatric infectious diseases to medical, pharmacy, and nursing students during monthly rotations.  Journal Of Medical Education. Vol. 57, no. 8. (August): e640.
• Nahata MC; Durrell DE; Barson WJ. 1982. Moxalactam epimer kinetics in children.  Clinical Pharmacology And Therapeutics. Vol. 31, no. 4. (April): e528.
• Barson WJ; Nahata MC. 1982. Moxalactam in pediatrics.  Drug Intelligence & Clinical Pharmacy. Vol. 16, no. 2. (February): e113.
• Barson WJ; Craenen J; Hosier DM; Brawley RL; Hilty MD. 1981. Survival following myocarditis and myocardial calcification associated with infection by Coxsackie virus B-4.  Pediatrics. Vol. 68, no. 1. (July): e79.
• Brawley RL; Barson WJ; Palmer R; Hilty MD; Koranyi K. 1980. Acute septic arthritis caused by Neisseria meningitidis serogroup W-135.  Southern Medical Journal. Vol. 73, no. 3. (March): e395.
• Pietropaolo D, Magee M, Kneiper R, et al. 0. Should all young febrile infants 60 days of age or younger be tested for enterovirus in CSF by PCR?. In Pediatric Academic Societies Annual Meeting
• Kaplan SL, Barson WJ, Lin P, et al. 0. Early trends for invasive pneumococcal infections in children following the introduction of the 13-valent pneumococcal conjugate vaccine. In IDSA
• Mason EO Jr, Wald ER, Tan TQ, Schutze GE, Bradley JS, Barson WJ, Givner LB, Hoffman J, Kaplan SL. Recurrent systemic pneumococcal disease in children. The Pediatric Infectious Disease Journal 26(6): 480-484, 2007.

• Listed, Best Doctors in America